Mar 26, 2015

Dividend Growth Stock Purchase - GILD (10 shares, $17 dividend income)

Gilead Sciences (NASDAQ: GILD) is a biotechnology company that specializes in antiviral drugs for HIV, hepatitis B, influenza and pulmonary diseases.

This company has had impressive revenues growth recently (more than 100% year over year) and for the first time in company history will be paying out dividends this year. This is a good sign and shows confidence by the company management team going forward and I want to invest in them.

To paraphrase hockey great Wayne Gretzky"I skate to where the puck is going to be" .
I want to own this company before the dividend train arrives :))

Basic info:
Market CAP: 149B Dividend %: 1.7% (based on $0.43 dividend starting 2nd qtr 2015)

No comments:

Post a Comment